You are here

COMPASS Pathways

Largest psilocybin trial finds the psychedelic is effective in treating serious depression

Stat

Tue, 11/9/21 - 11:37 pm

psychedelic drugs

treatment-resistant depression

COMPASS Pathways

clinical trials

MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO

Pharmaforum

Tue, 09/22/20 - 12:13 pm

COMPASS Pathways

psychedelic drugs

magic mushrooms

Compass raises $80M to take magic mushroom drug toward phase 3

Fierce Biotech

Mon, 04/27/20 - 09:25 am

COMPASS Pathways

magic mushrooms

treatment-resistant depression

In a key step for psychedelic research, magic mushroom compound clears first clinical safety hurdle

Endpoints

Thu, 12/12/19 - 05:35 pm

antidepressants

COMPASS Pathways

Psilocybin Therapy for Treatment-Resistant Depression is Being Taken Seriously by Regulators as FDA Gives Go-Ahead to Clinical Trial

Xtalks

Fri, 08/24/18 - 11:03 am

COMPASS Pathways

treatment-resistant depression